Tarsus Pharmaceuticals, Inc. TARS Temporary differences related to Texas Margin Tax
Temporary differences related to Texas Margin Tax at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s temporary differences related to texas margin tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s temporary differences related to texas margin tax?
- Tarsus Pharmaceuticals, Inc. (TARS) reported temporary differences related to texas margin tax of $13.64M in Q4 2025.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s temporary differences related to texas margin tax?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s temporary differences related to texas margin tax has grown at a 128.7% compound annual growth rate (CAGR), from $1.14M to $13.64M.